IBER NYSE
Ibere Pharmaceuticals
1W: +0.1%
1M: +0.3%
3M: +2.2%
1Y: +5.6%
$10.18
Last traded 2023-03-01 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$139M
+20408.2% ▲
Total Liabilities
$12M
+1656.0% ▲
Shareholders Equity
$127M
+660837.5% ▲
Cash & Investments
$458K
+161.4% ▲
Total Debt
$0
-100.0% ▼
Net Debt
-$458K
-7100.6% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 |
|---|---|---|
| — Assets — | ||
| Cash | $175K | $458K |
| Short-Term Investments | $0 | $0 |
| Cash & ST Investments | $175K | $458K |
| Net Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other Current Assets | $0 | $235K |
| Total Current Assets | $175K | $693K |
| Property, Plant & Equip. | $0 | $0 |
| Goodwill & Intangibles | $0 | $0 |
| Long-Term Investments | $0 | $0 |
| Other Non-Current Assets | $0 | $138M |
| Total Non-Current Assets | $501K | $138M |
| Total Assets | $676K | $139M |
| — Liabilities — | ||
| Accounts Payable | $0 | $0 |
| Short-Term Debt | $169K | $0 |
| Deferred Revenue | $0 | $0 |
| Other Current Liabilities | $488K | $372K |
| Total Current Liabilities | $657K | $372K |
| Long-Term Debt | $0 | $0 |
| Other Non-Current Liab. | $0 | $11M |
| Total Non-Current Liabilities | $0 | $11M |
| Total Liabilities | $657K | $12M |
| — Equity — | ||
| Common Stock | $345 | $138M |
| Retained Earnings | -$6K | -$11M |
| Accumulated OCI | $0 | $0 |
| Total Stockholders Equity | $19K | $127M |
| Total Liabilities & Equity | $676K | $139M |
| — Key Metrics — | ||
| Total Debt | $169K | $0 |
| Net Debt | -$6K | -$458K |
| Total Investments | $0 | $0 |